hiw are patients screened for glp-1 drugs in colorado What Is Orforglipron? Inside a CU Anschutz Clinical Trial a New Oral GLP -1 Weight-Loss Drug Starting GLP-1 in Colorado Springs:

Insight: The Mounjaro Effect and Novo Nordisks Strategic Pivot Eli Lilly's dual-action drug, Mounjaro (tirzepatide, marketed as Zepbound for obesity), has been a phenomenal market disrupter

doi: 10.1016/j.cmet.2022.07.013 80 le RouxCWSteenOLucasKJStartsevaEUnseldAHennigeAM

BMJ Open 2013;3:e001986.ArticlePubMedPMC 33

For patients without a history of pancreatitis who are considering GLP-1 therapy, discussing your individual risk profile with your healthcare provider before starting treatment allows for informed decision-making

Steps to support safety The study outlines several strategies care teams can use when patients remain on GLP-1 medications

cravings for high-fat foods, sugary foods, and alcohol are diminished